MedNation AG

DB:EIF Stock Report

Market Cap: €11.3m

MedNation Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for MedNation.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth12.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article • Feb 03

Estimating The Intrinsic Value Of MedNation AG (FRA:EIF)

Key Insights MedNation's estimated fair value is €3.78 based on 2 Stage Free Cash Flow to Equity Current share price of...
Analysis Article • Dec 14

Returns Are Gaining Momentum At MedNation (FRA:EIF)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article • Oct 30

Calculating The Intrinsic Value Of MedNation AG (FRA:EIF)

Key Insights Using the 2 Stage Free Cash Flow to Equity, MedNation fair value estimate is €3.82 MedNation's €3.30 share...
Analysis Article • Oct 03

MedNation AG (FRA:EIF) Soars 49% But It's A Story Of Risk Vs Reward

Despite an already strong run, MedNation AG ( FRA:EIF ) shares have been powering on, with a gain of 49% in the last...
Analysis Article • Aug 19

The Market Lifts MedNation AG (FRA:EIF) Shares 27% But It Can Do More

DB:EIF 1 Year Share Price vs Fair Value Explore MedNation's Fair Values from the Community and select yours The...
Analysis Article • Aug 19

MedNation AG's (FRA:EIF) Shares Leap 27% Yet They're Still Not Telling The Full Story

DB:EIF 1 Year Share Price vs Fair Value Explore MedNation's Fair Values from the Community and select yours MedNation...
Analysis Article • May 31

MedNation (FRA:EIF) Is Doing The Right Things To Multiply Its Share Price

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article • Nov 19

Investors Will Want MedNation's (FRA:EIF) Growth In ROCE To Persist

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...
Analysis Article • Oct 07

MedNation's (FRA:EIF) Earnings Are Weaker Than They Seem

MedNation AG's ( FRA:EIF ) robust earnings report didn't manage to move the market for its stock. Our analysis suggests...
Analysis Article • Oct 03

Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost

MedNation AG ( FRA:EIF ) shareholders have had their patience rewarded with a 25% share price jump in the last month...
Analysis Article • Oct 03

Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost

The MedNation AG ( FRA:EIF ) share price has done very well over the last month, posting an excellent gain of 25%. The...
Analysis Article • Mar 06

The Return Trends At MedNation (FRA:EIF) Look Promising

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Analysis Article • Jan 03

Investors Still Aren't Entirely Convinced By MedNation AG's (FRA:EIF) Revenues Despite 31% Price Jump

MedNation AG ( FRA:EIF ) shares have had a really impressive month, gaining 31% after a shaky period beforehand. Not...
Analysis Article • Dec 23

These 4 Measures Indicate That MedNation (FRA:EIF) Is Using Debt Extensively

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Oct 10

MedNation (FRA:EIF) Is Looking To Continue Growing Its Returns On Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article • Jul 29

MedNation AG's (FRA:EIF) 32% Dip In Price Shows Sentiment Is Matching Earnings

MedNation AG ( FRA:EIF ) shareholders won't be pleased to see that the share price has had a very rough month, dropping...
Analysis Article • Jun 29

Returns On Capital Are Showing Encouraging Signs At MedNation (FRA:EIF)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Analysis Article • Dec 03

Returns Are Gaining Momentum At Eifelhöhen-Klinik (FRA:EIF)

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Analysis Article • Oct 09

These 4 Measures Indicate That Eifelhöhen-Klinik (FRA:EIF) Is Using Debt Extensively

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Jun 03

Is Eifelhöhen-Klinik (FRA:EIF) Using Debt Sensibly?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Oct 16

Is Eifelhöhen-Klinik (FRA:EIF) Using Debt In A Risky Way?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Jun 07

Is Eifelhöhen-Klinik (FRA:EIF) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Feb 22

Will Eifelhöhen-Klinik's (FRA:EIF) Growth In ROCE Persist?

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MedNation has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

DB:EIF - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202553312N/A
9/30/2025511N/AN/AN/A
6/30/202550012N/A
3/31/202549012N/A
12/31/202449012N/A
9/30/2024491N/AN/AN/A
6/30/202449222N/A
3/31/202447112N/A
12/31/202345011N/A
9/30/202343-101N/A
6/30/202341-201N/A
3/31/202340-201N/A
12/31/202239-201N/A
9/30/202239-322N/A
6/30/202239-334N/A
3/31/202238-434N/A
12/31/202137-434N/A
9/30/202136-323N/A
6/30/202135-222N/A
3/31/202136-233N/A
12/31/202036-145N/A
9/30/202039-234N/A
6/30/202042-223N/A
3/31/202046-123N/A
12/31/201950-123N/A
9/30/201950-1N/A3N/A
6/30/201951-1N/A3N/A
3/31/201951-1N/A2N/A
12/31/201851-1N/A0N/A
9/30/201850-1N/A1N/A
6/30/2018490N/A2N/A
3/31/2018490N/A2N/A
12/31/2017480N/A2N/A
9/30/2017480N/A1N/A
6/30/201748-1N/A1N/A
3/31/2017492N/A1N/A
12/31/2016495N/A1N/A
9/30/2016495N/A2N/A
6/30/2016495N/A3N/A
3/31/2016482N/A2N/A
12/31/201547-1N/A1N/A
9/30/201546-1N/A2N/A
6/30/201544-1N/A2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if EIF's forecast earnings growth is above the savings rate (1.9%).

Earnings vs Market: Insufficient data to determine if EIF's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if EIF's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if EIF's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if EIF's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if EIF's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/17 21:47
End of Day Share Price 2026/06/17 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MedNation AG is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.